scholarly article | Q13442814 |
P356 | DOI | 10.1002/1529-0131(200109)44:9<2185::AID-ART372>3.0.CO;2-3 |
P698 | PubMed publication ID | 11592384 |
P2093 | author name string | Ralston SH | |
Del Soldato P | |||
Armour KE | |||
Armour KJ | |||
Torbergsen AC | |||
van 't Hof RJ | |||
P2860 | cites work | Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat | Q28244187 |
Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis | Q33570152 | ||
Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption | Q34138159 | ||
Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption | Q35174052 | ||
Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture | Q37175923 | ||
Bone disease in rheumatoid arthritis | Q39631185 | ||
Anorectic activity of prostaglandin precursors | Q40021154 | ||
Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells | Q41068395 | ||
Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties | Q41208757 | ||
The Michael Mason Prize Essay 1997. Nitric oxide and bone: what a gas! | Q41590242 | ||
Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells | Q42468869 | ||
Effects of interleukin-1 on bone turnover in normal mice | Q43625701 | ||
Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures. | Q45984716 | ||
Acute myocardial infarction enhances the portal venous histamine level in dogs. | Q50939737 | ||
Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
Osteoblastic cells are involved in osteoclast formation. | Q54374668 | ||
A diclofenac derivative without ulcerogenic properties | Q60695451 | ||
Evidence for a Pathogenic Role of Nitric Oxide in Inflammation-Induced Osteoporosis | Q64448951 | ||
Cytokine-Induced Nitric Oxide Inhibits Bone Resorption by Inducing Apoptosis of Osteoclast Progenitors and Suppressing Osteoclast Activity | Q64448955 | ||
NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects | Q73094778 | ||
Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats | Q73640217 | ||
Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro | Q73832169 | ||
Frequency-dependent effect of nitric oxide donor nitroglycerin on bone | Q73858627 | ||
Role of nitric oxide and prostaglandins in mechanically induced bone formation | Q74647618 | ||
Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study | Q77650576 | ||
Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro | Q77765531 | ||
P433 | issue | 9 | |
P304 | page(s) | 2185-2192 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026). | |
P478 | volume | 44 |
Q44480304 | Changes in vasoactive factors associated with altered vessel morphology in the tibial metaphysis during ovariectomy-induced bone loss in rats |
Q47669705 | NO and HNO donors, nitrones, and nitroxides: Past, present, and future |
Q30497308 | Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility |
Q24672983 | Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs |
Q36052815 | Recent developments in nitric oxide donor drugs. |
Q74496943 | Safer non-steroidal anti-inflammatory drugs: are cyclo-oxygenase inhibitors or nitric oxide non-steroidal anti-inflammatory drugs the grand finale? |
Search more.